In Silico Evaluation of Phytoestrogens as Targeted Modulators of Hormonal Receptors (ESR1 and PGR) in Amenorrhea: A Comprehensive Bioinformatics and Molecular Docking Approach.
Ananya Tripathi , Department of Chemistry, Amity School of Applied Science, Amity University, Uttar Pradesh, Lucknow Campus, India Sangeeta Bajpai , Department of Chemistry, Amity School of Applied Science, Amity University, Uttar Pradesh, Lucknow Campus, IndiaAbstract
Amenorrhea is a condition where a woman does not get her period. This condition is often related to problems with the pituitary-ovarian axis. The pituitary-ovarian axis is a system that helps control when a woman gets her period. Amenorrhea is also associated with changes in the way that hormonal receptors work. These hormonal receptors, such as Estrogen Receptor alpha and Progesterone Receptor are important for a woman to have a menstrual cycle.
Hormone replacement therapy is one way that doctors treat Amenorrhea. However using hormone replacement therapy for a time can cause problems with a womans metabolism. Because of this doctors need to find ways to treat Amenorrhea.
This study looked at how certain phytoestrogens, such as Quercetin, Genistein, Diosgenin, Apigenin and Vitexin might be used to treat Amenorrhea. The study used computers to analyze the information, which is called a bioinformatics-based approach. The researchers wanted to see if these phytoestrogens, such as Quercetin, Genistein, Diosgenin, Apigenin and Vitexin could be used as an alternative, to hormone replacement therapy. The molecular docking analysis was performed using AutoDock Vina for determining their binding interactions with ESR1 (PDB ID: 1A52) and PGR (PDB ID: 1A28). Docking studies revealed that Quercetin exhibited the highest binding affinity for PGR at -9.74 kcal / mol, and Diosgenin exhibited the strongest binding with ESR1 at -8.88 kcal / mol.
The team did research on how these compounds work in the body and if they are safe. They used tools like SwissADME and pkCSM to see how well the body absorbs these compounds and if they are toxic. The results showed that these compounds are absorbed well in the stomach and are generally safe.
In the end the team thinks that these natural compounds could work like steroids to affect hormone levels and might be options to study for new treatments, for amenorrhea.
Keywords
Amenorrhea, HPO axis, ESR1, PGR, molecular docking, phytochemicals, ADMET, bioinformatics
References
Valera H, Chen A, Grive KJ. The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging. Endocrinology. 2025 Sep 8;166(10):bqaf137. doi: 10.1210/endocr/bqaf137. PMID: 40884186; PMCID: PMC12448947.
Popat VB, Prodanov T, Calis KA, Nelson LM. The menstrual cycle: a biological marker of general health in adolescents. Ann N Y Acad Sci. 2008;1135:43-51. doi: 10.1196/annals.1429.040. PMID: 18574207; PMCID: PMC2755071.
Lambalk CB. The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone. F S Rep. 2023 Apr 24;4(2 Suppl):27-32. doi: 10.1016/j.xfre.2023.02.010. PMID: 37223768; PMCID: PMC10201305.
Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J. 2009;56(6):729-37. doi: 10.1507/endocrj.k09e-185. Epub 2009 Jul 17. PMID: 19609045; PMCID: PMC4307809.
Moore, S. W. (2011). A. Griffith’s Instructions for Patients, 1–28. https://doi.org/10.1016/b978- 1-4377-0909-4.50003-8
Monroig, P. C., & Calin, G. A. (2015). Drug–MicroRNA Cross-Talk. MicroRNA in Regenerative Medicine, 837–862. https://doi.org/10.1016/b978-0-12-820719-2.00032-6
Wan B, Chen W, Shan M, Chi L. Immune modulation by sex hormones: unveiling the complex interplay and regulatory networks. Front Immunol. 2026 Feb 26;17:1748097. doi: 10.3389/fimmu.2026.1748097. PMID: 41836442; PMCID: PMC12979564.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric. 2021 Dec;24(6):533-550. doi: 10.1080/13697137.2021.1891773. Epub 2021 Apr 1. PMID: 33792440.
Harper-Harrison, G., Carlson, K., & Shanahan, M. M. (2024, October 6). Hormone Replacement Therapy. Nih.Gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493191/#:~:text=However%2C%20while%20these% 20outcomes%20are,use%20and%20not%20FDA%2Dapproved.
Gorzkiewicz J, Bartosz G, Sadowska-Bartosz I. The Potential Effects of Phytoestrogens: The Role in Neuroprotection. Molecules. 2021 May 16;26(10):2954. doi: 10.3390/molecules26102954. PMID: 34065647; PMCID: PMC8156305.
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334. PMID: 19499576; PMCID: PMC3041641.
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1). https://doi.org/10.1038/srep42717
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., … Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057. https://doi.org/10.1038/nrdp.2016.57
Gordon, C. M., Ackerman, K. E., & Berga, S. L. (2017). Functional hypothalamic amenorrhea: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(5), 1413–1439. https://doi.org/10.1210/jc.2017-00131
Hall, J. E. (2021). Guyton and Hall textbook of medical physiology (14th ed.). Elsevier.
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., … Gustafsson, J. Å. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87(3), 905–931. https://doi.org/10.1152/physrev.00026.2006
Klein, D. A., Paradise, S. L., & Reeder, R. M. (2019). Amenorrhea: A systematic approach to diagnosis and management. American Family Physician, 100(1), 39–48.
Krassas, G. E., Poppe, K., & Glinoer, D. (2010). Thyroid function and human reproductive health. Endocrine Reviews, 31(5), 702–755. https://doi.org/10.1210/er.2009-0041
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. (2011). Diagnosis and treatment of hyperprolactinemia. The Journal of Clinical Endocrinology & Metabolism, 96(2), 273–288.
Practice Committee of the American Society for Reproductive Medicine. (2020). Current evaluation of amenorrhea. Fertility and Sterility, 113(6), e1–e7.
Reindollar, R. H. (2003). Primary amenorrhea: Investigation, management, and prognosis. Fertility and Sterility, 80(2), 317–325.
Wetendorf, M., & DeMayo, F. J. (2012). The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Molecular and Cellular Endocrinology, 357(1–2), 108–118.
Download and View Statistics
Copyright License
Copyright (c) 2026 Ananya Tripathi, Sangeeta Bajpai

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Applied Sciences
| Open Access |
DOI: